Table 5.
Adenosine receptor affinitities of deazaxanthines and azaxanthines
| Ki (nM)a | |||||
|---|---|---|---|---|---|
| A1 | A2A | A2B | A3 | ||
| Deazaxanthines | |||||
| 109 | 9-Deaza-theophylline | 5,400 (r)1 | 12,000 (r)1 | nd | nd |
| 110 | 9-Deazacaffeine | 32,000 (r)1 | 72,000 (r)1 | nd | nd |
| 111 | 7-Deaza-theophylline | 43,000 (r)1 | >250,000 (r)1 | nd | nd |
| 112 | 1,3-Dimethyl-8-phenyl-9-deazaX | 47 (r)1 | 510 (r)1 | nd | nd |
| 113 | 1,3-Dipropyl-8-phenyl-9-daX | 13 (r)1 | 450 (r)1 | nd | nd |
| 114 | 1-Methyl-8-phenyl-9-deazaX | 97 (r)1 | 2000 (r)1 | 520 (h)2 | 2098 (h)2 |
| 115 | 1-Propyl-8-phenyl-9-daX | 45 (h)2 39 (r)1 |
>10,000 (h)2 1,200 (r)1 |
42 (h)2 | 380 (h)2 |
| 116 | 1,3-Dimethyl-8-phenyl-7-deazaX | 3,1001 | 12,0001 | nd | nd |
| 117 | 14.8 (h)3 | 64.6 (h)3 | 3.02 (h)3 | >1,000 (h)3 | |
| 118 | >1,000 (h)4 | 10,000 (h)4 | 11.0 (h)4 | >1,000 (h)4 | |
| 119 | 89.1 (h)4 | 324 (h)4 | 2.04 (h)4 | 2,240 (h)4 | |
| 120 | 676 (h)4 | 3,550 (h)4 | 5.26 (h)4 | >1,000 (h)4 | |
| 121 | 183 (h)5 | nd | 1 (h)5 | 12,260 (h)5 | |
| 122 | Tricyclic 9-DeazaX | 346 (h)6 | 164 (h)6 | nd | 3.82 (h)6 |
| 8-Azaxanthines | |||||
| 123 | 1,3-Dimethyl-8-cyclopentyl-8-azaX | 110,000 (c)7 | 58,000 (c)7 | nd | nd |
| 124 | 1,3-Dipropyl-8-cyclopentyl-8-azaX | 1,300 (c)7 | 13,000 (c)7 | nd | nd |
| 125 | 1,3-Dimethyl-7-cyclopentyl-8-azaX | 11,000 (c)7 | 292,000 (c)7 | nd | nd |
| 126 | 1,3-Dipropyl-7-cyclopentyl-8-azaX | 340 (c)7 | 10,000 (c)7 | nd | nd |
h = human; c = cow; r = rat; a few A2B data may be from functional (cAMP) studies; nd = no data available